News Focus
News Focus
Followers 24
Posts 4104
Boards Moderated 0
Alias Born 12/18/2019

Re: Roman516 post# 736307

Sunday, 12/08/2024 11:52:52 PM

Sunday, December 08, 2024 11:52:52 PM

Post# of 818083
PFS was the PRIMARY endpoint of the trial and DCVax-L failed to meet it. PFS was the AGREED to endpoint by both the FDA and NWBO. Only when NWBO saw they were going to fail to meet it, they change the protocol and tossed out the PFS primary endpoint. FDA knew it and that's why NWBO didn't file an FDA application.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News